Health Decision Analysis: Evolution, Trends, and Emerging Topics

Published Online:https://doi.org/10.1287/deca.2022.0460

References

  • Ahsen ME, Ayvaci MUS, Raghunathan S (2019) When algorithmic predictions use human-generated data: A bias-aware classification algorithm for breast cancer diagnosis. Inform. Systems Res. 30(1):97–116.LinkGoogle Scholar
  • Ahuja VA, Alvarez C, Birge JR, Syverson C (2021) Enhancing regulatory decision making for postmarket drug safety. Management Sci. 67(12):7493–7510.LinkGoogle Scholar
  • Akan M, Alagoz O, Ata B, Erenay FS, Said A (2012) A broader view of designing the liver allocation system. Oper. Res. 60(4):757–770.LinkGoogle Scholar
  • Alfaro L, Faia E, Lamersdorf N, Saidi F (2022) Health externalities and policy: The role of social preferences. Management Sci. 68(9):6751–6761.Google Scholar
  • Anderer A, Bastani H, Silberholz J (2022) Adaptive clinical trial designs with surrogates: When should we bother? Management Sci. 68(3):1982–2002.LinkGoogle Scholar
  • Angelis A, Kanavos P, Montibeller G (2017a) Resource allocation and priority setting in healthcare: A multi-criteria decision analysis problem of value? Global Policy 8(S2):76–83.CrossrefGoogle Scholar
  • Angelis A, Montibeller G, Hochhauser D, Kanavos P (2017b) Multiple criteria decision analysis in the context of health technology assessment: A simulation exercise on metastatic colorectal cancer with multiple stakeholders in the English setting. BMC Medical Inform. Decision Making 17:149.CrossrefGoogle Scholar
  • Ayer T, Alagoz O, Stout NK, Burnside ES (2016) Heterogeneity in women’s adherence and its role in optimal breast cancer screening policies. Management Sci. 62(5):1339–1362.LinkGoogle Scholar
  • Ayer T, Zhang C, Bonifonte A, Spaulding AC, Chhatwal J (2019) Prioritizing hepatitis C treatment in US prisons. Oper. Res. 67(3):853–873.LinkGoogle Scholar
  • Bertsimas D, O’Hair A, Relyea S, Silberholz J (2016) An analytics approach to designing combination chemotherapy regimens for cancer. Management Sci. 62(5):1511–1531.LinkGoogle Scholar
  • Bonifonte A, Ayer T, Haaland B (2022) An analytics approach to guide randomized controlled trials in hypertension management. Management Sci. 68(9):6634–6647.Google Scholar
  • Brauer F, Castillo-Chávez C, Feng Z (2019) Mathematical Models in Epidemiology (Springer-Verlag, New York).CrossrefGoogle Scholar
  • Bravo F, Corcoran TC, Long EF (2022) Flexible drug approval policies. Manufacturing Service Oper. Management 24(1):542–560.LinkGoogle Scholar
  • Brookes VJ, Hernández-Jover M, Cowled B, Holyoake PK, Ward MP (2014) Building a picture: Prioritisation of exotic diseases for the pig industry in Australia using multi-criteria decision analysis. Preventive Veterinary Medicine 113:103–117.CrossrefGoogle Scholar
  • Carland C, Goentzel J, Montibeller G (2018) Modeling the values of private sector agents in multi-echelon humanitarian supply chains. Eur. J. Oper. Res. 269:532–543.CrossrefGoogle Scholar
  • Chen W, Lu Y, Qiu L, Kumar S (2021) Designing personalized treatment plans for breast cancer. Inform. Systems Res. 32(3):932–949.LinkGoogle Scholar
  • Copenhaver MS, Hu M, Levi R, Safavi K, Zenteno Langle AC (2019) Health system innovation: Analytics in action. Netessine S, ed. Operations Research & Management Science in the Age of Analytics (Catonsville, MD), 238–266.Google Scholar
  • Cox R, Sanchez J, Revie CW (2013) Multi-criteria decision analysis tools for prioritising emerging or re-emerging infectious diseases associated with climate change in Canada. PLoS One 8(8):e68338.CrossrefGoogle Scholar
  • De Nardo P, Gentilotti E, Mazzaferri F, Cremonini E, Hansen P, Goossens H, Tacconelli E, et al. (2020) Multi-criteria decision analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage. Internat. J. Infectious Diseases 98:494–500.CrossrefGoogle Scholar
  • Del Rio Vilas VJ, Burgeño A, Montibeller G, Clavijo A, Vigilato MA, Cosivi O (2013a) Prioritization of capacities for the elimination of dog-mediated human rabies in the Americas: Building the framework. Pathogens Global Health 107(7):340–345.CrossrefGoogle Scholar
  • Del Rio Vilas VJ, Voller F, Montibeller G, Franco LA, Sribhashyam S, Watson E, Hartley M, et al. (2013b) An integrated process and management tools for ranking multiple emerging threats to animal health. Preventive Veterinary Medicine 108(2–3):94–102.CrossrefGoogle Scholar
  • Denton BT (2018) Optimization of sequential decision making for chronic diseases: From data to decisions. Gel E, Ntaimo L, eds. Recent Advances in Optimization and Modeling of Contemporary Problems (Catonsville, MD), 316–348.Google Scholar
  • Dyer JS, Smith JE (2020) Innovations in the science and practice of decision analysis: The role of management science. Management Sci. 67(9):5364–5378.Google Scholar
  • Felder S, Mayrhofer T (2017) Medical Decision Making (Springer, Berlin).CrossrefGoogle Scholar
  • Franco LA, Montibeller G (2010) Facilitated modelling in operational research. Eur. J. Oper. Res. 205(3):489–500.CrossrefGoogle Scholar
  • Gökçinar A, Çakanyıldırım M, Price T, Adams MCB (2022) Balanced opioid prescribing via a clinical trade-off: Pain relief vs. adverse effects of discomfort, dependence, and tolerance/hypersensitivity. Decision Anal., ePub ahead of print February 3, https://doi.org/10.1287/deca2021.0447.Google Scholar
  • Gouglas D, Marsh K (2019) Prioritizing investments in new vaccines against epidemic infectious diseases: A multi-criteria decision analysis. J. Multi-Criteria Decision Anal. 26(3-4):153–163.CrossrefGoogle Scholar
  • Grand-Clément J, Chan C, Goyal V, Chuang E (2021) Interpretable machine learning for resource allocation with application to ventilator triage. Preprint, submitted October 21, https://arxiv.org/abs/2110.10994.Google Scholar
  • Guan P, Zhuang J (2015) Modeling public–private partnerships in disaster management via centralized and decentralized models. Decision Anal. 12(4):173–189.LinkGoogle Scholar
  • Guyse JL, Keller LR, Huynh CH (2020) Valuing sequences of lives lost or saved over time: Preference for uniform sequences. Decision Anal. 17(1):24–38.LinkGoogle Scholar
  • Hajjar A, Alagoz O (2022) personalized disease screening decisions considering a chronic condition. Management Sci., ePub ahead of print March 25, https://doi.org/10.1287/mnsc.2022.4336.Google Scholar
  • Henry E, Loseto M, Ottaviani M (2022) Regulation with experimentation: Ex ante approval, ex post withdrawal, and liability. Management Sci. 68(7):5330–5347.LinkGoogle Scholar
  • Hunink MM, Weinstein MC, Wittenberg E, Drummond MF, Pliskin JS, Wong JB, Glasziou PP (2014) Decision Making in Health and Medicine: Integrating Evidence and Values, 2nd ed. (Cambridge University Press, Cambridge, UK).CrossrefGoogle Scholar
  • Jaspersen JG, Montibeller G (2015) Probability elicitation under severe time pressure: A rank-based method. Risk Anal. 35(7):1317–1335.CrossrefGoogle Scholar
  • Jónasson JO, Kaw N, Sinha D, Trichakis N, Chen A, Conte J, Restaino A, et al. (2021) Preventing opioid overdose: From prediction to operationalization. Preprint, submitted July 22, https://dx.doi.org/10.2139/ssrn.3842424.Google Scholar
  • Kattan M, Cowen M (2009) Encyclopedia of Medical Decision Making (SAGE Publications).CrossrefGoogle Scholar
  • Kc DS, Scholtes S, Terwiesch C (2020) Empirical research in healthcare operations: Past research, present understanding, and future opportunities. Manufacturing Service Oper. Management 22(1):73–83.LinkGoogle Scholar
  • Keefer DL, Kirkwood CW, Corner JL (2004) Perspective on decision analysis applications, 1990–2001. Decision Anal. 1(1):4–22.LinkGoogle Scholar
  • Keller LR, Simon J, Wang Y (2009) Multiple-objective decision analysis involving multiple stakeholders. Oskoorouchi M, ed. Decision Technologies and Applications (Catonsville, MD), 139–155.Google Scholar
  • Kleinmuntz DN (2007) Resource allocation decisions. Edwards W, Miles RF, von Winterfeldt D, eds. Advances in Decision Analysis: From Foundations to Applications (Cambridge University Press, New York), 400–418.CrossrefGoogle Scholar
  • Kloeber J (2011) Current and cutting edge methods of portfolio decision analysis in pharmaceutical R&D. Salo A, Keisler J, Morton A, eds. Portfolio Decision Analysis, vol. 162. International Series in Operations Research & Management Science (Springer, New York), 283–331.CrossrefGoogle Scholar
  • Kouvelis P, Milner J, Tian Z (2017) Clinical trials for new drug development: Optimal investment and application. Manufacturing Service Oper. Management 19(3):437–452.LinkGoogle Scholar
  • Krischer JP (1980) An annotated bibliography of decision analytic applications to healthcare. Oper. Res. 28(1):97–113.LinkGoogle Scholar
  • Lee HK, Li J, Bain PA, Baker C (2022) Optimal intervention policies for total joint replacement postoperative care process. Manufacturing Service Oper. Management 24(1):617–631.LinkGoogle Scholar
  • Long EF, Chen MK, Rohla R (2020) Political storms: Emergent partisan skepticism of hurricane risks. Sci. Adv. 6(37):eabb7906.CrossrefGoogle Scholar
  • Long EF, Nohdurft E, Spinler S (2018) Spatial resource allocation for emerging epidemics: A comparison of greedy, myopic, and dynamic policies. Manufacturing Service Oper. Management 20(2):181–198.LinkGoogle Scholar
  • Methling F, Borden SA, Veeraraghavan D, Sommer I, Siebert JU, von Nitzsch R, Seidler M (2022) Supporting innovation in early-stage pharmaceutical development decisions. Decision Anal., ePub ahead of print April 7, https://doi.org/10.1287/deca2022.0452.LinkGoogle Scholar
  • Montibeller G (2018) Behavioral challenges in policy analysis with conflicting objectives. Gel E, Ntaimo L, eds. Recent Advances in Optimization and Modeling of Contemporary Problems (INFORMS, Catonsville, MD), 85–108.Google Scholar
  • Montibeller G (2022) Decision Making for Enhanced Health Security: Managing Emerging Health Threats, Making Reasoned Choices, and Allocating Scarce Resources, vol. 328. International Series in Operations Research & Management Science (Springer International Publishing, Berlin).CrossrefGoogle Scholar
  • Montibeller G, von Winterfeldt D (2018) Individual and group biases in value and uncertainty judgments. Dias LC, Morton A, Quigley J, eds. Elicitation. International Series in Operations Research & Management Science (Springer, Cham, Switzerland), 377–392.CrossrefGoogle Scholar
  • Montibeller G, Franco LA, Carreras A (2020a) A risk analysis framework for prioritizing and managing biosecurity threats. Risk Anal. 40(11):2462–2477.CrossrefGoogle Scholar
  • Montibeller G, Patel P, Del Rio Vilas VJ (2020b) A critical analysis of multi-criteria models for the prioritisation of health threats. Eur. J. Oper. Res. 281(1):87–99.CrossrefGoogle Scholar
  • Nelson C, Lurie N, Wasserman J, Zakowski S (2007) Conceptualizing and defining public health emergency preparedness. Amer. J. Public Health 97:S9–S11.CrossrefGoogle Scholar
  • Nohdurft E, Long E, Spinler S (2017) Was Angelina Jolie right? Optimizing cancer prevention strategies among BRCA mutation carriers. Decision Anal. 14(3):139–169.LinkGoogle Scholar
  • Obermeyer Z, Powers B, Vogeli C, Mullainathan S (2019) Dissecting racial bias in an algorithm used to manage the health of populations. Science 366(6464):447–453.CrossrefGoogle Scholar
  • Oliveira MD, Mataloto I, Kanavos P (2019) Multi-criteria decision analysis for health technology assessment: Addressing methodological challenges to improve the state of the art. Eur. J. Health Econom. 20(6):891–918.CrossrefGoogle Scholar
  • Phillips LD, Bana e Costa CA (2007) Transparent prioritisation, budgeting and resource allocation with multi-criteria decision analysis and decision conferencing. Ann. Oper. Res. 154(1):51–68.CrossrefGoogle Scholar
  • Rode DC, Fischbeck PS (2021) On ambiguity reduction and the role of decision analysis during the pandemic. Risk Anal. 41(5):721–730.CrossrefGoogle Scholar
  • Rojas-Cordova AC, Hosseinichimeh N (2018) Trial termination and drug misclassification in sequential adaptive clinical trials. Service Sci. 10(3):354–377.LinkGoogle Scholar
  • Rosenstrom E, Meshkinfam S, Ivy JS, Hassani Ghoodarzi S, Capan M, Huddleston J, Romero-Brufau S (2022) Optimizing the first response to sepsis: An electronic health recorded-based Markov decision process model. Decision Anal., ePub ahead of print July 22, https://doi.org/10.1287/deca2022.0455.LinkGoogle Scholar
  • Salo A, Keisler J, Morton A (2011) Portfolio Decision Analysis: Improved Methods for Resource Allocation (Springer, Berlin).CrossrefGoogle Scholar
  • Schwartz A, Bergus G (2008) Medical Decision Making: A Physician’s Guide (Cambridge University Press, Cambridge, UK).CrossrefGoogle Scholar
  • Serra-Garcia M, Szech N (2022) Incentives and defaults can increase COVID-19 vaccine intentions and test demand. Management Sci., ePub ahead of print May 6, https://doi.org/10.1287/mnsc.2022.4405.Google Scholar
  • Skandari MR, Shechter SM (2021) Patient-type Bayes-adaptive treatment plans. Oper. Res. 69(2):574–598.LinkGoogle Scholar
  • Small C, Bickel JE (2022) Model complexity and accuracy: A COVID-19 case study. Decision Anal., ePub ahead of print July 21, https://doi.org/10.1287/deca2022.0457.Google Scholar
  • Smith JE, von Winterfeldt D (2004) Anniversary article: Decision analysis in management science. Management Sci. 50(5):561–574.LinkGoogle Scholar
  • Sox H, Higgins M, Owens D (2013) Medical Decision Making (Wiley, New York).CrossrefGoogle Scholar
  • Spetzler C, Winter H, Meyer J, eds. (2016) Decision Quality Value Creation from Better Business Decisions (John Wiley & Sons, Hoboken, NJ).CrossrefGoogle Scholar
  • Stonebraker JS (2002) How Bayer makes decisions to develop new drugs. Interfaces 32:77–90.LinkGoogle Scholar
  • Taheri E, Wang C (2018) Eliciting public risk preferences in emergency situations. Decision Anal. 15(4):223–241.LinkGoogle Scholar
  • Tian Z, Han W, Powell WB (2022) Adaptive learning of drug quality and optimization of patient recruitment for clinical trials with dropouts. Manufacturing Service Oper. Management 24(1):580–599.LinkGoogle Scholar
  • Wan Q, Xu X, Chen X, Zhuang J (2020) A two-stage optimization model for large-scale group decision-making in disaster management: Minimizing group conflict and maximizing individual satisfaction. Group Decision Negotiations 29(5):901–921.CrossrefGoogle Scholar
  • Wan Q, Xu X, Hunt K, Zhuang J (2022) Stay home or not? Modeling individuals’ decisions during the COVID-19 pandemic. Decision Anal., ePub ahead of print September 7, https://doi.org/10.1287/deca2021.0437.Google Scholar
  • Willis HH, Moore M (2014) Improving the value of analysis for biosurveillance. Decision Anal. 11(1):63–81.LinkGoogle Scholar
  • Xu L, Zhao H, Petruzzi NC (2021) Inducing compliance with postmarket studies for drugs under FDA’s accelerated approval pathway. Manufacturing Service Oper. Management 23(1):170–190.LinkGoogle Scholar
  • Zawadzki M, Montibeller G (2022) A framework for supporting health capability based planning: Identifying and structuring health capabilities. Risk Anal., ePub ahead of print September 18, https://doi.org/10.1111/risa.14014.CrossrefGoogle Scholar
INFORMS site uses cookies to store information on your computer. Some are essential to make our site work; Others help us improve the user experience. By using this site, you consent to the placement of these cookies. Please read our Privacy Statement to learn more.